Anthropometric Measures and Severity of Gastroesophageal Reflux Disease

Completed

• Conditions: Gastroesophageal Reflux Disease

• Registration Number: NCT01954667
• Lead Sponsor: Ain Shams University

Brief Summary

evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2013-08
• Study Completion: 2013-08
• Status Verified: 2013-09
• Study First Submitted: 2013-09-29
• Study First Submitted QC: 2013-09-29
• Last Update Submitted: 2013-09-29
• Study First Posted: 2013-10-07
• Last Update Posted: 2013-10-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Gastro esophageal reflux symptoms (e.g. heart burn, regurgitation, water brash or atypical symptoms such as hoarseness of voice, asthma and cough)
• complete upper gastrointestinal endoscopy.

Exclusion Criteria

• Receiving medication for reflux disease (including proton pump inhibitor, histamine type 2 receptors blocker, prokinetic agents) in the previous month.
• Pregnant woman.
• History of upper abdominal surgery.
• Severe co-morbidity as cirrhosis, end-stage renal disease and heart failure.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Impact of anthropometric measures on GERD	1 year	evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.

Trial Locations

Locations (1)

Tropical medicine department; 🇪🇬 Cairo, Egypt